 SAN DIEGO, June 22, 2020 GLOBE NEWSWIRE -- aTyr Pharma, Inc. LIFE, a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced a poster and audio presentation at the 2020 American Association for Cancer Research AACR Virtual Annual Meeting II, which is being held June 22 24, 2020. The poster is available for browsing on the AACR website from June 22 24, 2020. The poster presents findings from a preclinical study, conducted in collaboration with Dr. Arthur M. Mercurio and his lab at the University of Massachusetts Medical School, demonstrating that aTyr has generated a panel of anti-human NRP2 monoclonal antibodies that have the potential to be developed for the clinical management of solid tumors. 